5:25 PM ET
8-K
Capital Raise
Sunshine Biopharma Capital Raise of $6M
Sunshine Biopharma Inc. closed a best efforts public offering of approximately 10.9 million units for gross proceeds of $6.0 million. Each unit, priced at $0.55, consists of one share of common stock (or a pre-funded warrant) and two Series D warrants. The company intends to use the net proceeds for general corporate purposes and working capital.
- Value
- $6M
- Counterparty
- Aegis Capital Corp.